Results 121 to 130 of about 2,912,633 (312)

Early Clinical, Imaging, and Pathological Characteristics of SRPK3/TTN‐Digenic Myopathy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective SRPK3/TTN‐digenic myopathy was recently established as a skeletal muscle myopathy caused by digenic inheritance. This study characterizes the early clinical presentation of SRPK3/TTN‐digenic myopathy in one previously reported and seven newly identified pediatric patients.
Rotem Orbach   +23 more
wiley   +1 more source

Portrait of Guy Warren, 1992 [picture] /

open access: yes, 1992
Title from label on back of print.; Part of the collection: Portraits of Australian artists 1968-1993.; Reference print at P641/14/R.; Also available in electronic version via the Internet at: http://nla.gov.au/nla.pic ...
Weight, Greg, 1946-
core  

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin   +11 more
wiley   +1 more source

Portrait of Robert Jacks, 2001 [picture] /

open access: yes, 2001
Part of collection: Portraits of six Australian artists. Title supplied by vendor.Portrait taken in Robert Jack's studio, Harcourt, Victoria, 22 March 2001.
Weight, Greg, 1946-
core  

Association Between Motor Pathway Damage and Motor Deficit in Upper and Lower Limb in People With MS

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Corticospinal tract damage is common in people with MS, but the degree of clinical symptoms varies. We hypothesize that corticospinal tract lesions are more extensive and severe in people with MS with motor impairments in both upper and lower limbs.
Mathilde Liffran   +13 more
wiley   +1 more source

Portrait of Justin O'Brien, 1993 [picture] /

open access: yes, 1993
Title from label on back of print.; Part of the collection: Portraits of Australian artists 1968-1993.; Reference print at P641/18/R.; Also available online at: http://nla.gov.au/nla.pic-an12090944; Exhibited: "Sublime", The Gallery, National Library of ...
Weight, Greg, 1946-
core  

Bone healing in rats submitted to weight-bearing and non-weight-bearing exercises.

open access: yesMedical science monitor : international medical journal of experimental and clinical research, 2008
To investigate the effects of low-intensity exercise on bone healing during a short time.We made a surgical 1-mm perforation in the upper third medial cortical of the right tibia of 45 male Wistar rats (3 months old; mean weight, 282+/-34 g). Animals were randomly assigned to a swimming exercise group (SWIM, n=15), a running exercise group (RUN, n=15),
Carlos Romualdo, Rueff-Barroso   +6 more
openaire   +1 more source

Long‐Term Efficacy of Immunotherapy in Autoimmune Autonomic Ganglionopathy—A 10‐Year Follow Up Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Autoimmune autonomic ganglionopathy (AAG) is a rare but potentially treatable cause of severe autonomic failure. Evidence guiding long‐term immunotherapy, treatment sequencing, and residual autonomic impairment is limited. We evaluated long‐term treatment response, residual autonomic dysfunction, and relapse patterns in patients with
Giacomo Chiaro   +6 more
wiley   +1 more source

Portrait of John Bell, 1968 [picture] /

open access: yes, 1968
Title from label on back of print.; Part of the collection: Portraits of Australian artists 1968-1993.; Reference print at P641/22/R.; Also available online at: http://nla.gov.au/nla.pic ...
Weight, Greg, 1946-
core  

Unraveling 4‐Phenylbutyrate's Therapeutic Role in SLC6A1 Disorders: Pharmacochaperoning Over HDAC Inhibition

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Variants in SLC6A1, encoding the GABA transporter 1 (GAT‐1), cause epilepsy, autism spectrum disorder, and developmental delay via loss of GABA uptake, impaired trafficking, and ER retention. We previously found that 4‐Phenylbutyrate (PBA), an FDA‐approved drug, restores GABA uptake and reduces seizures in SLC6A1‐related disorders ...
Melissa B. DeLeeuw   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy